MINOCYCLINE VERSUS VANCOMYCIN FOR TREATMENT OF EXPERIMENTAL ENDOCARDITIS CAUSED BY OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS

被引:26
|
作者
NICOLAU, DP
FREEMAN, CD
NIGHTINGALE, CH
COE, CJ
QUINTILIANI, R
机构
[1] HARTFORD HOSP,DEPT PHARM,HARTFORD,CT 06115
[2] HARTFORD HOSP,DEPT RES,HARTFORD,CT 06115
[3] UNIV CONNECTICUT,SCH PHARM,STORRS,CT 06268
[4] UNIV CONNECTICUT,SCH MED,FARMINGTON,CT 06032
关键词
D O I
10.1128/AAC.38.7.1515
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The purpose of this study was to determine the penetration of minocycline and vancomycin into cardiac vegetations and to determine their efficacy in a rabbit model of endocarditis caused by oxacillin-resistant Staphylococcus aureus. Animals were randomized into three groups: control (no antibiotic), minocycline (6 mg/kg given intravenously every 8 h), and vancomycin (50 mg/kg given intravenously every 8 h). Penetration of the antibiotics into aortic valve vegetations was determined by using the tissue/serum area under the concentration-time curve ratio. The reductions in the bacterial density of the vegetations caused by both vancomycin (4.8 +/- 1.2 CFU/g) and minocycline (5.3 +/- 1.6 CFU/g) were significantly different from that of controls (8.7 +/- 1.8 CFU/g). Although the penetration of minocycline was twice that of vancomycin, they were equally effective in reducing the bacterial density of the vegetations, since the concentrations of both agents in tissue remained above their MICs for oxacillin-resistant S. aureus. For organisms for which the MICs are higher, however, these penetration differences may result in treatment differences.
引用
收藏
页码:1515 / 1518
页数:4
相关论文
共 50 条
  • [1] VANCOMYCIN THERAPY OF OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS INFECTIONS
    KLASTERSKY, J
    COPPENS, L
    VANDERAUWERA, P
    MEUNIERCARPENTIER, F
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 11 (04) : 361 - 367
  • [2] VANCOMYCIN TREATMENT OF BACTEREMIA CAUSED BY OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS - COMPARISON WITH BETA-LACTAM ANTIBIOTIC-TREATMENT OF BACTEREMIA CAUSED BY OXACILLIN-SENSITIVE STAPHYLOCOCCUS-AUREUS
    CRAVEN, DE
    KOLLISCH, NR
    HSIEH, CR
    CONNOLLY, MG
    MCCABE, WR
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (01): : 137 - 143
  • [3] POTENTIAL OF CLINDAMYCIN IN ADDITION TO VANCOMYCIN FOR THE TREATMENT OF OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS SEPTICEMIA PERSISTING UNDER VANCOMYCIN THERAPY
    VENDITTI, M
    BAIOCCHI, P
    SANTINI, C
    GALETTA, P
    TARASI, A
    BRANDIMARTE, C
    DARGENIO, P
    CAMPAGNANO, P
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1995, 5 (02) : 123 - 128
  • [4] Adults with meningitis caused by oxacillin-resistant Staphylococcus aureus
    Lu, CH
    Chang, WN
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 31 (03) : 723 - 727
  • [5] ORAL TEMAFLOXACIN VERSUS VANCOMYCIN FOR THERAPY OF EXPERIMENTAL ENDOCARDITIS CAUSED BY METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
    HESSEN, MT
    PITSAKIS, PG
    KAYE, D
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (06) : 1143 - 1145
  • [6] Failure of Cloxacillin in Treatment of a Patient with Borderline Oxacillin-Resistant Staphylococcus aureus Endocarditis
    Skinner, Stuart
    Murray, Melanie
    Walus, Tom
    Karlowsky, James A.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (03) : 859 - 861
  • [7] MUPIROCIN RESISTANCE AMONG CONSECUTIVE ISOLATES OF OXACILLIN-RESISTANT AND BORDERLINE OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS AT A UNIVERSITY HOSPITAL
    LAYTON, MC
    PATTERSON, JE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) : 1664 - 1667
  • [8] TEICOPLANIN VERSUS NAFCILLIN AND VANCOMYCIN IN THE TREATMENT OF EXPERIMENTAL ENDOCARDITIS CAUSED BY METHICILLIN-SUSCEPTIBLE OR METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
    CHAMBERS, HF
    SANDE, MA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (01) : 61 - 64
  • [9] Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides
    Rello, J
    Sole-Violan, J
    Sa-Borges, M
    Garnacho-Montero, J
    Muñoz, E
    Sirgo, G
    Olona, M
    Diaz, E
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (09) : 1983 - 1987
  • [10] CIPROFLOXACIN VERSUS VANCOMYCIN IN THE THERAPY OF EXPERIMENTAL METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS ENDOCARDITIS
    KAATZ, GW
    BARRIERE, SL
    SCHABERG, DR
    FEKETY, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (04) : 527 - 530